Coordinating center for multicancer screening tests
NCI Cancer Screening Research Network: Coordinating and Communication Center
['FUNDING_OTHER'] · FRED HUTCHINSON CANCER CENTER · NIH-11248803
This project will see if new blood-based tests that look for many cancers at once can help find cancers earlier in adults who are eligible for screening.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | FRED HUTCHINSON CANCER CENTER (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11248803 on ClinicalTrials.gov |
What this research studies
You would be part of a national effort to try two promising multicancer detection blood tests in a real-world setting. People will be randomly assigned to receive one of the tests or usual screening, and the study team will track what happens after any positive test result. The team will record how quickly a specific cancer diagnosis is reached, which follow-up procedures are used, how much they cost, and how the process affects worry and other health outcomes. The coordinating center at Fred Hutch will work with statistical and data centers and clinical sites across the country to run the trial.
Who could benefit from this research
Good fit: Adults without a current cancer diagnosis who are eligible for routine cancer screening and willing to undergo a blood-based multicancer screen and any recommended follow-up would be the ideal participants.
Not a fit: People with a current diagnosed cancer, those unwilling or unable to complete recommended diagnostic follow-up, or those outside participating clinical catchment areas may not benefit from joining this effort.
Why it matters
Potential benefit: If successful, these tests could enable earlier detection of multiple cancers from a single blood draw, potentially improving treatment options and outcomes.
How similar studies have performed: Early studies of multicancer detection tests have shown promise for finding multiple cancers, but strong evidence on mortality benefit and real-world follow-up pathways is still limited.
Where this research is happening
SEATTLE, UNITED STATES
- FRED HUTCHINSON CANCER CENTER — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ANDERSON, GARNET L. — FRED HUTCHINSON CANCER CENTER
- Study coordinator: ANDERSON, GARNET L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Burden, Cancers